Related topics

Global Drug Eluting Implants Market 2018-2023 Expected to Reach $8.12 Billion - ResearchAndMarkets.com

April 4, 2018

DUBLIN--(BUSINESS WIRE)--Apr 4, 2018--The “Global Drug Eluting Implants Market - Forecasts from 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global drug eluting implants market is expected to reach US$8.120 billion by the end of 2023, increasing from US$5.594 billion in 2017, growing at a CAGR of 6.41% during the forecast period.

Growing adoption of these devices and increasing expenditure in the field of research and development will be the major factors driving the demand for these implants. North America and Europe held a significant share in 2017 and the Asia Pacific region is projected grow at an impressive rate over the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Major industry players profiled as part of the report are Boston Scientific, ProMed Pharma, Elixir Medical Corporation, iVascular, and Abbott Laboratories among others.

Key Topics Covered

1. Introduction

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base and Forecast Years Timeline

2. Research Methodology

2.1. Research Design

2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Force Analysis

4.5.1. Bargaining Power of Suppliers

4.5.2. Bargaining Power of Buyers

4.5.3. Threat of New Entrants

4.5.4. Threat of Substitutes

4.5.5. Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. Global Drug Eluting Implants Market by Type

5.1. Biodegradable Drug Eluting Implants

5.2. Non-Biodegradable Drug Eluting Implants

6. Global Drug Eluting Implants Market by Application

6.1. Cardiology

6.2. Oncology

6.3. Diabetes Treatment

6.4. Pain Treatment

6.5. Others

7. Global Drug Eluting Implants Market by Geography

7.1. North America

7.2. South America

7.3. Europe

7.4. Middle East and Africa

7.5. Asia Pacific

8. Competitive Intelligence

8.1. Market Share Analysis

8.2. Investment Analysis

8.3. Recent Deals

8.4. Strategies of Key Players

9. Company Profiles

9.1. iVascular

9.2. ProMed Pharma

9.3. Johnson & Johnson

9.4. Boston Scientific

9.5. Merck

9.6. Medtronic

9.7. Biosensors International Group

9.8. Abbott Laboratories

9.9. Elixir Medical Corporation

9.10. Siemens Healthcare

For more information about this report visit https://www.researchandmarkets.com/research/3x2x7f/global_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180404006092/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Delivery



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 04/04/2018 02:10 PM/DISC: 04/04/2018 02:10 PM


Update hourly